Cargando…
Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction
BACKGROUND: It has been demonstrated that soluble epoxide hydrolase inhibitors (sEHIs) are protective against ischemia-induced lethal arrhythmias, but the mechanisms involved are unknown. Previously, we showed that sEHIs might reduce the incidence of ischemic arrhythmias by suppressing microRNA-1 (m...
Autores principales: | Gui, Yajun, Li, Da, Chen, Jingyuan, Wang, Yating, Hu, Jiahui, Liao, Caixiu, Deng, Limin, Xiang, Qunyan, Yang, Tao, Du, Xiao, Zhang, Shilan, Xu, Danyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975509/ https://www.ncbi.nlm.nih.gov/pubmed/29843720 http://dx.doi.org/10.1186/s12944-018-0780-y |
Ejemplares similares
-
Soluble epoxide hydrolase inhibitors, t-AUCB, regulated microRNA-1 and its target genes in myocardial infarction mice
por: Gui, Ya-Jun, et al.
Publicado: (2017) -
Soluble Epoxide Hydrolase in Atherosclerosis
por: Wang, Yi-Xin Jim, et al.
Publicado: (2010) -
Soluble Epoxide Hydrolase Inhibitors Regulate Ischemic Arrhythmia by Targeting MicroRNA-1
por: Chen, Yanying, et al.
Publicado: (2021) -
Soluble Epoxide Hydrolase and Diabetes Complications
por: Anita, Natasha Z., et al.
Publicado: (2022) -
Soluble Epoxide Hydrolase Inhibitor t-AUCB Ameliorates Vascular Endothelial Dysfunction by Influencing the NF-κB/miR-155-5p/eNOS/NO/IκB Cycle in Hypertensive Rats
por: Wang, Xiaorui, et al.
Publicado: (2022)